Peer-influenced content. Sources you trust. No registration required. This is HCN.
Pharmacy Practice News
According to the findings of the study, gabapentin should not be used on a regular basis. Individualization is required, based on the type of pain and the risk of delirium. If gabapentin is used to control postoperative pain, it must be closely monitored for the development of delirium. Low-dose opioids, along with nonpharmacologic pain management strategies such as postoperative physical therapy and mobilization, can still be used safely in the study population. Rather than relying on a single medication, a more holistic approach to postoperative pain control in the hospital setting is required.
Anesthesiology January 30th 2023
Infectious Disease Special Edition (IDSE)
Reports on the Vaccine Safety Datalink flagged the need to investigate a potential increased risk those 65 years of age and older, for ischemic stroke in the first 21 days after receiving the bivalent Pfizer-BioNTech booster. FDA has parallel monitoring systems to confirm or fail to validate a safety signal. In this case, those other systems did not confirm the Vaccine Safety Datalink flag.
Allergy & Immunology January 24th 2023
Psychiatrist.com
In comparing PTSD to PTSD plus sexual abuse, minors with PTSD following sexual abuse are more likely to suffer MDD, substance use disorder, and suicidal behavior.
Internal Medicine January 24th 2023
JAMA Network
This review summarizes current understanding of and approaches to autism spectrum disorder and emphasizes that first-line therapy focuses on behavioral interventions.
Family Medicine/General Practice January 24th 2023
Addiction Professional
The US Department of Health and Human Services’ (HHS) Substance Abuse and Mental Health Services Administration (SAMHSA) issued the 2021 National Survey on Drug Use and Health (NSDUH) this week. The NDSUH offers a window into Americans’ experiences with mental health disorders, substance use, and their pursuit of treatment during the second year of the COVID epidemic through chosen estimates by race, ethnicity, and age group. Enough said—the outcomes aren’t appealing.
Family Medicine/General Practice January 18th 2023
Journal of Neurology, Neurosurgery & Psychiatry
When there was insufficient or conflicting evidence, core authors from the Autoimmune Encephalitis Alliance Clinicians Network assessed the literature and administered an electronic survey to each member to get their personal opinions. The poll received 68 responses from respondents in 17 different nations. For patients with a general presentation, 84% of responders chose corticosteroids alone or in combination with other treatments (intravenous IG or plasmapheresis), 74% for patients who presented with faciobrachial dystonic seizures, 63% for NMDAR-IgG encephalitis, and 48.5% for classical paraneoplastic encephalitis. A summary of the diagnostic and therapeutic recommendations is provided at the end of the manuscript, which also includes a detailed presentation of the survey data.
Neurology January 18th 2023